Clinical Study

A Study Of The Contraceptive Efficacy, Safety And Tolerability Of The Ag200-15 Transdermal Contraceptive Delivery System (Birth Control Patch).

Posted Date: May 15, 2019

  • Investigator: Michael Thomas
  • Specialties:
  • Type of Study: Drug

This study is enrolling healthy females at least 18 years old with regular menstrual cycles who are seeking a birth control method for a year. The investigational birth control patch contains LNG (levonorgestrel) and EE (ethinyl estradiol), which are active ingredients in some Food and Drug Administ

Criteria:

This Study Is Enrolling Healthy Females At Least 18 Years Old With Regular Menstrual Cycles Who Are

Keywords:

Women, Contraceptive, Pregnancy, Ob/Gyn, Birth Control

For More Information:

Jennifer Golan
(513) 584-4100
jennifer.golan@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.